Article Text

Download PDFPDF
Diabetes mellitus: what the neurologists need to know
  1. Jeffrey Wayne Stephens1,
  2. David M Williams2,
  3. Richard Chudleigh3
  1. 1Diabetes Research Group, Swansea University Medical School, Swansea, UK
  2. 2Diabetes Centre, Morriston Hospital, Swansea, UK
  3. 3Diabetes Centre, Singleton Hospital, Swansea, UK
  1. Correspondence to Professor Jeffrey Wayne Stephens, Diabetes, Swansea University Medical School, Swansea, Swansea, UK; j.w.stephens{at}swansea.ac.uk

Abstract

Diabetes mellitus is a common condition associated with numerous complications and comorbidities. The diabetes spectrum includes type 1, type 2 and other forms of diabetes, which may be associated with medical therapies and genetic factors. Type 2 diabetes is managed with lifestyle, oral therapies, non-insulin-based injectables and subsequently insulin. Type 1 diabetes requires insulin from the time of diagnosis. In recent years, there have been considerable developments in the therapies available to treat type 2 diabetes and some of these also afford cardiorenal protection. This review summarises the nature, complications and therapeutic advances in the field of diabetes and provides a concise review for neurologists. Managing diabetes optimally prevents complications and all medical specialties need a basic understanding of the principles involved in diabetes care.

  • diabetes mellitus

Data availability statement

No data are available.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

No data are available.

View Full Text

Footnotes

  • Contributors All authors have contributed to the preparation of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally reviewed by Gareth Llewelyn, Gwent, UK, Suzanne Phillips, Gloucester, UK and Martin Sadler, Plymouth, UK.

Other content recommended for you